AJOVista’s Solid Biosciences SLDB Stock Holding History

AJOVista’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,806	Closed	-$23.4K	–	361
2023 Q4	$23.4K	Buy	+3,806	New	+$12.2K	0.03%	350

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

AJOVista's SLDB Position: Q1 2024 in Review

AJOVista sold out of Solid Biosciences (SLDB) in Q1 2024, closing a stake of 3,806 shares — an estimated $23.4K sold.

AJOVista first reported a position in SLDB in Q4 2023 and held it in 1 quarter. The position peaked at $23.4K in Q4 2023. 55 funds tracked by Wall St. Rank hold SLDB as of Q1 2024.

AJOVista reported no remaining Solid Biosciences position as of Q1 2024 after selling out during the quarter.
AJOVista sold 3,806 Solid Biosciences shares in Q1 2024, an estimated $23.4K.
AJOVista first reported a position in Solid Biosciences in Q4 2023 and held it in 1 quarter.
AJOVista's Solid Biosciences position peaked at $23.4K in Q4 2023.
55 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.